EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies

Daniel Thomas Jones iD, Rishi Kumar Nanda, Abbas Ali Hussain, Riccesha Hattin, Yin Mon Myat, Rajat Thawani iD, Jeremy Cetnar, Mohamed Shanshal iD, Kyaw Zin Thein iD, Shivaani Kummar

Cancers · 06.03.2026 · 18 (5) · 856

DOI: 10.3390/cancers18050856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.03.2026. Verfasst von Daniel Thomas Jones und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Sunrise Health GME Consortium, Las Vegas, NV 89148, USA. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Tissue-agnostic therapy has transformed oncology by enabling treatment selection based on molecular alterations rather than tumor origin. Since 2017, nine U.S. Food and Drug Administration approvals across six biomarker classes have defined this paradigm. Thoracic and head and neck (H&N) cancers have been underrepresented in the registrational evidence supporting these approvals. This review systematically evaluated biomarker representation, histologic distribution, and clinical applicability of tissue-agnostic therapies in thoracic and H&N malignancies.

Methods

A narrative systematic review was conducted using PubMed, ClinicalTrials.gov, and regulatory documents for all tissue-agnostic approvals between January 2017 and October 2025. Data were extracted from pivotal trials, including total enrollment, objective response rate (ORR), histologic distribution, and thoracic/H&N representation. Emerging biomarkers and resistance mechanisms were assessed from phase I–III studies and basket trials.

Results

Nine tissue-agnostic approvals encompassing six biomarkers were identified: MSI-H/dMMR, TMB-High, NTRK, RET, BRAF V600E, and HER2 (IHC 3+). Across pivotal datasets (3800 patients), thoracic and H&N cancers accounted for fewer than 8% (n = 290) of enrolled patients. Thoracic representation was dominated by non-small-cell lung cancer (NSCLC) in RET, NTRK, and HER2 programs (150 patients, 4%), while small-cell lung, mesothelioma, and thymic carcinomas contributed

Schlagwörter

Stichwörter der Autor:innen

BRAF V600EHER2 IHC 3+MSI-H/dMMRNTRK fusionRET fusionTMB-Highbiomarker-driven therapyhead and neck cancernext-generation sequencingthoracic cancertissue-agnostic oncologytumor-agnostic therapy

Autor:innen und Institutionen

  • Department of Internal Medicine, Sunrise Health GME Consortium, Las Vegas, NV 89148, USA.
  • College of Osteopathic Medicine, Touro University Nevada, Las Vegas, NV 89014, USA.
  • Department of Internal Medicine, Kirk Kerkorian School of Medicine at University of Nevada, Las Vegas (UNLV), Las Vegas, NV 89106, USA.
  • Department of Internal Medicine, Interfaith Medical Center, Brooklyn, NY 11213, USA.
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA.
  • Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

ORCID-Profile: Daniel Thomas Jones, Rajat Thawani, Mohamed Shanshal, Kyaw Zin Thein

Zitieren

APA

Jones, D. T., Nanda, R. K., Hussain, A. A., Hattin, R., Myat, Y. M., Thawani, R., Cetnar, J., Shanshal, M., Thein, K. Z., & Kummar, S. (2026). Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies. Cancers, 18(5), 856. https://doi.org/10.3390/cancers18050856

Vancouver

Jones DT, Nanda RK, Hussain AA, Hattin R, Myat YM, Thawani R, et al. Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies. Cancers. 2026;18(5):856. doi:10.3390/cancers18050856

BibTeX
@article{Jones2026,
  author = {Jones, Daniel Thomas and Nanda, Rishi Kumar and Hussain, Abbas Ali and Hattin, Riccesha and Myat, Yin Mon and Thawani, Rajat and Cetnar, Jeremy and Shanshal, Mohamed and Thein, Kyaw Zin and Kummar, Shivaani},
  title = {Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {856},
  doi = {10.3390/cancers18050856}
}
Kostenlos starten →